Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Connor

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Vaccines|September 21, 2017
Host Transcriptional Response to Ebola Virus InfectionEmily Speranza, John H Connor
Journal of Virology|September 20, 2002
Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1John H Connor, Douglas S Lyles
Methods in Molecular Biology (Clifton, N.J.)|April 5, 2017
Generating Recombinant Vesicular Stomatitis Viruses for Use as Vaccine PlatformsJohn B Ruedas, John H Connor
DNA and Cell Biology|January 13, 2017
Hypusination of eIF5A as a Target for Antiviral TherapyMichelle E Olsen, John H Connor
The Journal of Biological Chemistry|February 12, 2005
Inhibition of host and viral translation during vesicular stomatitis virus infection. eIF2 is responsible for the inhibition of viral but not host translationJohn H Connor, Douglas S Lyles
Progress in Molecular Biology and Translational Science|February 21, 2012
HijAkt: The PI3K/Akt pathway in virus replication and pathogenesisEwan F Dunn, John H Connor
Journal of Virology|October 29, 2010
Dominant inhibition of Akt/protein kinase B signaling by the matrix protein of a negative-strand RNA virusEwan F Dunn, John H Connor
Methods (San Diego, Calif.)|September 27, 2012
Translational control by negative-strand RNA viruses: methods for the study of a crucial virus/host interactionErin N Hodges, John H Connor
Journal of Virology|September 11, 2009
Akt inhibitor Akt-IV blocks virus replication through an Akt-independent mechanismEwan F Dunn, Rachel Fearns, John H Connor
Scientific Reports|January 7, 2023
A high-throughput single-particle imaging platform for antibody characterization and a novel competition assay for therapeutic antibodiesElif Seymour, M Selim Ünlü, John H Connor
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Vaccines|September 21, 2017
Host Transcriptional Response to Ebola Virus InfectionEmily Speranza, John H Connor
Journal of Virology|September 20, 2002
Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1John H Connor, Douglas S Lyles
Methods in Molecular Biology (Clifton, N.J.)|April 5, 2017
Generating Recombinant Vesicular Stomatitis Viruses for Use as Vaccine PlatformsJohn B Ruedas, John H Connor
DNA and Cell Biology|January 13, 2017
Hypusination of eIF5A as a Target for Antiviral TherapyMichelle E Olsen, John H Connor
The Journal of Biological Chemistry|February 12, 2005
Inhibition of host and viral translation during vesicular stomatitis virus infection. eIF2 is responsible for the inhibition of viral but not host translationJohn H Connor, Douglas S Lyles
Progress in Molecular Biology and Translational Science|February 21, 2012
HijAkt: The PI3K/Akt pathway in virus replication and pathogenesisEwan F Dunn, John H Connor
Journal of Virology|October 29, 2010
Dominant inhibition of Akt/protein kinase B signaling by the matrix protein of a negative-strand RNA virusEwan F Dunn, John H Connor
Methods (San Diego, Calif.)|September 27, 2012
Translational control by negative-strand RNA viruses: methods for the study of a crucial virus/host interactionErin N Hodges, John H Connor
Journal of Virology|September 11, 2009
Akt inhibitor Akt-IV blocks virus replication through an Akt-independent mechanismEwan F Dunn, Rachel Fearns, John H Connor
Scientific Reports|January 7, 2023
A high-throughput single-particle imaging platform for antibody characterization and a novel competition assay for therapeutic antibodiesElif Seymour, M Selim Ünlü, John H Connor
Pageof 14